| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |